Sharon L Bober1,2, Alexis L Michaud3, Christopher J Recklitis3,4. 1. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. Sharon_bober@dfci.harvard.edu. 2. Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Sharon_bober@dfci.harvard.edu. 3. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. 4. Harvard Medical School, 25 Shattuck Street, Boston, MA, USA.
Abstract
PURPOSE: Sexual dysfunction is one of the most prevalent and distressing treatment-related side effects for both male and female cancer survivors. Survivorship care guidelines recommend therapeutic sexual aids to help improve sexual problems. However, little is known about the availability of sexual aids and resources at cancer centers. METHODS: Twenty-five comprehensive cancer centers affiliated with both the National Cancer Institute and the National Comprehensive Care Network were surveyed using the "mystery shopper" method to determine whether various types of sexual aids were available at the centers. Staffs from cancer center staff retail stores and patient boutiques were queried in separate telephone calls regarding the availability of these aids for and women. RESULTS: Of the 25 centers contacted, 23 (92%) responded about aids for men, and 22 (88%) responded about aids for women. Eighty-seven percent of the centers reported having no sexual aids available for men, and 72% of centers reported having no aids available for women. The most common advice given to mystery shoppers was a suggestion to use the internet. Only one center had numerous aids/resources for both men and women. CONCLUSIONS: The large majority of cancer centers reported having no sexual aids or other sexual health resources available for men or women. IMPLICATIONS FOR CANCER SURVIVORS: Results underscore the widespread lack of resources to promote sexual health rehabilitation at major cancer centers, both for male and female survivors.
PURPOSE:Sexual dysfunction is one of the most prevalent and distressing treatment-related side effects for both male and female cancer survivors. Survivorship care guidelines recommend therapeutic sexual aids to help improve sexual problems. However, little is known about the availability of sexual aids and resources at cancer centers. METHODS: Twenty-five comprehensive cancer centers affiliated with both the National Cancer Institute and the National Comprehensive Care Network were surveyed using the "mystery shopper" method to determine whether various types of sexual aids were available at the centers. Staffs from cancer center staff retail stores and patient boutiques were queried in separate telephone calls regarding the availability of these aids for and women. RESULTS: Of the 25 centers contacted, 23 (92%) responded about aids for men, and 22 (88%) responded about aids for women. Eighty-seven percent of the centers reported having no sexual aids available for men, and 72% of centers reported having no aids available for women. The most common advice given to mystery shoppers was a suggestion to use the internet. Only one center had numerous aids/resources for both men and women. CONCLUSIONS: The large majority of cancer centers reported having no sexual aids or other sexual health resources available for men or women. IMPLICATIONS FOR CANCER SURVIVORS: Results underscore the widespread lack of resources to promote sexual health rehabilitation at major cancer centers, both for male and female survivors.
Entities:
Keywords:
Cancer; Cancer-related sexual dysfunction cancer survivorship; Sexual aids; Sexual health; Sexual rehabilitation
Authors: Eric S Zhou; Ann H Partridge; Karen L Syrjala; Alexis L Michaud; Christopher J Recklitis Journal: J Cancer Surviv Date: 2016-08-05 Impact factor: 4.442
Authors: Jeanne Carter; Christina Lacchetti; Barbara L Andersen; Debra L Barton; Sage Bolte; Shari Damast; Michael A Diefenbach; Katherine DuHamel; Judith Florendo; Patricia A Ganz; Shari Goldfarb; Sigrun Hallmeyer; David M Kushner; Julia H Rowland Journal: J Clin Oncol Date: 2017-12-11 Impact factor: 44.544
Authors: Emily K Hill; Stacey Sandbo; Emily Abramsohn; Jennifer Makelarski; Kristen Wroblewski; Emily R Wenrich; Stacy McCoy; Sarah M Temkin; S Diane Yamada; Stacy T Lindau Journal: Cancer Date: 2010-12-23 Impact factor: 6.860
Authors: Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian Journal: J Natl Compr Canc Netw Date: 2017-09 Impact factor: 11.908
Authors: Shari B Goldfarb; Emily Abramsohn; Barbara L Andersen; Shirley R Baron; Jeanne Carter; Maura Dickler; Judith Florendo; Leslie Freeman; Katherine Githens; David Kushner; Jennifer A Makelarski; S Diane Yamada; Stacy Tessler Lindau Journal: J Sex Med Date: 2013-02 Impact factor: 3.802
Authors: José A Bauermeister; Emily S Pingel; Laura Jadwin-Cakmak; Steven Meanley; Deepak Alapati; Michael Moore; Matthew Lowther; Ryan Wade; Gary W Harper Journal: AIDS Behav Date: 2015-10